Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
imaging, computer vision, and predictive modelling. The postdoc will further develop an existing rumen‑fill scoring algorithm into a functional prototype and pilot the technology for longitudinal monitoring
-
network modelling and machine learning for regulatory inference. - Functional validation of candidate TE‑CREs in spruce using UPSC transformation and somatic embryogenesis pipelines; evaluating drought
-
the health and MedTech sectors, and beyond. For more information about the total announced post-doctoral positions within in the AMBER co-fund project please visit https://www.euraxess.se/jobs/392999
-
of interest (but not limited to): Intersection of cybersecurity and AI, i.e., attacks and defenses leveraging AI solutions, or attacks and defenses within AI solutions (e.g., backdooring, model poisoning
-
information about the total announced post-doctoral positions within in the AMBER co-fund project please visit https://www.euraxess.se/jobs/392999 The interviews will start in April/May 2026. For more
-
positions within in the AMBER co-fund project please visit https://www.euraxess.se/jobs/392999 . The interviews will start in April/May 2026. For more information about AMBER, application and evaluation
-
cluster / micellar phases and arrested phase separation. We plan for theory-oriented work, combining analytical modeling based on liquid theory and coarse-grained simulations to explain experimental
-
-doctoral positions within in the AMBER co-fund project please visit https://www.euraxess.se/jobs/392999 The interviews will start in April/May 2026. For more information about AMBER, application and
-
information about the total announced post-doctoral positions within in the AMBER co-fund project please visit https://www.euraxess.se/jobs/392999 . The interviews will start in April/May 2026. For more
-
to identify candidate disease-causing variants. You will develop model systems, e.g. genome-editing of immune or induced pluripotent stem cells (iPSC) with specific patient-derived genetic variants. We aim